Long-Term Management of Sevelamer Hydrochloride-Induced Metabolic Acidosis Aggravation and Hyperkalemia in Hemodialysis Patients

REFERENCES

• National Kidney Foundation. K/DOQI™ clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42(Suppl. 3)51–52, [CSA]
   Google Scholar
• Chertow GM, Burke SK, Lazarus JM, et al. Poly [allylamine hydrochloride] (renagel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am J Kidney Dis 1997; 29(1)66–71, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chertow GM, Burke SK, Dillon MA, Slatopolski EA, for the Renagel® Study Group. Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of hemodialysis patients. Nephrol Dial Transplant 1999; 14: 2907–2914, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Yamada K, Fujimoto S, Nishiura R, et al. Effects of sevelamer on dyslipidemia and chronic inflammation in maintenance hemodialysis patients. J Am Soc Nephrol 2004; 14: 168A, [abstract][CSA], [CROSSREF]
   Google Scholar
• Chertow GM, Burke SK, Raggi P, et al. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 63: 245–252, [CSA], [CROSSREF]
   Google Scholar
• Gallieni M, Cozzolino M, Brancaccio D. Transient decrease of serum bicarbonate levels with sevelamer hydrochloride as the phosphate binder. Kidney Int 2000; 57(4)1776–1777, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Marco MP, Muray S, Betriu A, et al. Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients. Nephron 2002; 92: 499–500, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sadec T, Mazouz H, Bahloul H, et al. Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs. calcium carbonate in dialysis patients: an open label, randomized study. Nephrol Dial Transplant 2003; 18: 582–589, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sonikian M, Pani I, Iliopoulos A, et al. Metabolic acidosis aggravation and hyperkalemia in hemodialysis patients treated by sevelamer hydrochloride. Renal Failure 2005; 27: 143–147, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Mitch WE. Metabolic acidosis stimulates protein metabolism in uraemia. Miner Electolyte Metab 1996; 22: 62–65, [CSA]
   PubMedGoogle Scholar
• Brezina B, Qunib WY, Ndan CR. Acid loading during treatment with sevelamer hydrochloride: mechanisms and clinical implications. Kidney Int 2004; 66(Suppl. 90)39–45, [CSA], [CROSSREF]
   Google Scholar
• Wrong OM, Harland CE. Sevelamer-induced acidosis. Kidney Int 2005; 67(2)776, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Bommer J, Locatelli F, Satayathum S, et al. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44(4)661–671, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lowrie EG, Lew N. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458–482, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lefebvre A, De Vernejoul MC, Queris J, et al. Optimal correction of acidosis changes progression of dialysis osteodystrophy. Kidney Int 1989; 36: 1112–1118, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Williams AJ, Dittmer ID, McArley A, Clarke J. High bicarbonate dialysate in hemodialysis patients: effects on acidosis and nutritional status. Nephrol Dial Transplant 1997; 12: 2633–2637, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Lin S-H, Lin Y-F, Chin H-M, Wu C-C. Must metabolic acidosis be associated with malnutrition in hemodialysis patients?. Nephrol Dial Transplant 2002; 17: 2006–2010, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Brady JP, Hasbargen JA. Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients. Am J Kidney Dis 1998; 31: 35–40, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Graham KA, Reaich D, Channon SM, et al. Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int 1996; 49: 1396–1400, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Movilli E, Zani R, Carli O, et al. Correction of metabolic acidosis increases albumin concentrations and decreases kinetically evaluated protein intake in hemodialysis patients: a prospective study. Nephrol Dial Transplant 1998; 13: 1719–1722, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Sonikian M, Pani I, Koutala K, et al. Management of Acidosis Aggravation and Hyperkalaemia Associated with Sevelamer Hydrochloride Treatment in Dialysis Patients. Book of Abstracts of the XLIst Congress of the European Renal Association, European Dialysis and Transplant Association 2004; 104, Abstract SP264[CSA]
   Google Scholar
• Ciampi MA, Reilly RF. Long-term sevelamer use is associated with a higher serum phosphate, higher Ca × P product and lower serum bicarbonate than calcium-containing binders. J Am Soc Nephrol 2002; 13: 586A, [CSA]
   Google Scholar
• Heguilen RM, Sciurano C, Bellusci AD, Fried P, et al. The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic hemodialysis patients. Nephrol Dial Transplant 2005; 20: 591–597, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Nolan CR. Phosphate binder therapy for attainment of K/DOQI™ bone metabolism guidelines. Kidney Int 2005; 68(Suppl. 96)7–14, [CSA]
   Google Scholar
• Uribarri J, Levin NW, Delmez J, et al. Association of acidosis and nutritional parameters in hemodialysis patients. Am J Kidney Dis 1999; 34: 493–499, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Mehrotra R, Kopple JD, Wolfson M. Metabolic acidosis in maintenance dialysis patients: clinical considerations. Kidney Int 2003; 64(Suppl. 88)13–25, [CSA], [CROSSREF]
   Google Scholar
• Busevelamerinski DA. Net calcium efflux from live bone during chronic metabolic, but not respiratory, acidosis. Am J Physiol 1989; 256: F836–F842, [CSA]
   Google Scholar
• Graham KA, Hoenich NA, Tarbit M, et al. Correction of acidosis in hemodialysis patients increases the sensitivity of the parathyroid glands to calcium. J Am Soc Nephrol 1997; 8: 627–632, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar